The agmdhope’s Podcast

AGMD Conversations with Dr. Kenneth Koch - Differences Between Diabetic, Idiopathic, and Secondary Causes of Gastroparesis - December 2021

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, Dr. Koch will discuss the Differences Between Diabetic, Idiopathic, and Secondary Causes of Gastroparesis.
 
There will be ample time for questions towards the end of the program.
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
 
Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. AGMD
 

Conversations with Dr. Kenneth Koch - Gastroparesis Awareness Special - August 2022

AGMD is privileged to present our AGMD Conversations with Dr. Kenneth Koch, MD series.
Every other month, we will be talking with Dr. Koch and focusing on various topics related to gastroparesis.
August is Gastroparesis Awareness Month, and Dr. Koch answers questions about gastroparesis submitted by our audience participants.
Kenneth L. Koch, MD, is a Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |.

Conversations With Dr. Kenneth Koch - Diagnostic Tests For Gastroparesis - June 2022

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, Dr. Koch will discuss Diagnostic Tests For Gastroparesis.
 
There will be ample time for questions towards the end of the program.
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
 

AGMD Interview Featuring Laura Dotson, Interior Designer, Gastroparesis Patient, Advocate, & Co-Author Of A Book With Dr. Kenneth Koch

Laura A. Dotson is a native of North Carolina and a practicing interior designer. She graduated from Salem College, the University of North Carolina at Greensboro, and The Prince of Wales’s Institute of Architecture, with graduate work done at North Carolina University of Agriculture and Technical University. 
Because of her own medical journey, she has become an advocate for those who suffer from nausea and vomiting for any reason. 
Laura had her gallbladder removed. Immediately thereafter, she remained nauseated and would vomit 30-40 times per day.  Laura was misdiagnosed for a tormenting 18 months.  No one ought to live like that.
Her collaboration with Dr. Kenneth L. Koch as co-author of Comforting Your Uncomfortable Stomach: A companion for the Silent Sufferers of Nausea and Vomiting is a result of her finding the exact doctor she needed. Laura was referred to Dr. Koch in 2004 and diagnosed with severe gastroparesis. She is now healed and determined to share her experience to propagate education, heighten public awareness, and fundraise for research about the life-altering, silent, and lonely illnesses from which millions suffer that include the symptoms of nausea and vomiting. Silent No More is her goal!
Join us for this inspiration and informative program. You won't want to miss it!

Conversations With Dr. Kenneth Koch - Diagnosing And Subtyping Gastroparesis - February 2022

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, Dr. Koch will discuss Diagnosing and Subtyping Gastroparesis.
 
There will be ample time for questions towards the end of the program.
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
 
Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. AGMD
 

Conversations With Dr. Kenneth Koch - Gastroparesis & Irritable Bowel Disease - April 2022

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, Dr. Koch will discuss Gastroparesis & Irritable Bowel Syndrome.
 
There will be ample time for questions towards the end of the program.
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
 
Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. AGMD

An Interview with Michael DeGrazia - Whose Life Was Changed When He Suffered From An Anal Fissure, Fistula, And SIBO - Audio Edited By Matthew Petrulavage

Michael’s life was changed once he was diagnosed with an anal fissure, fistula, and small bowel intestinal overgrowth (SIBO). His faith became strengthened, and his understanding of GI problems and their impact became eye-opening. Michael now has compassion for all those suffering from digestive diseases and disorders and has a deeper appreciation of health and life itself.
Special thanks to Matthew Petrulavage for editing the recording. 
Owner | Plus One Productions - DJ Petro Entertainment
Music Producer & Live Event DJ/MC
 
Sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |
 
 

The Autonomic Nervous System, POTS, and Gastroparesis - June 2021

AGMD is proud to present our series featuring Dr. Kenneth Koch.  Every other month, we will be having a conversation with Dr. Koch and focusing on various topics related to gastroparesis.
 
This month, we will be highlighting the autonomic nervous system, POTS, and gastroparesis.
 
There will be ample time for audience questions towards the end of the interview.
 
Kenneth L. Koch, MD is Professor of Medicine, Section on Gastroenterology & Hepatology, at Wake Forest Baptist Medical Center. He has a career-long interest in understanding pathophysiological mechanisms of nausea and gastroparesis. Dr. Koch has studied extensively gastric myoelectrical activity (GMA) using serosal electrodes in animals and cutaneous electrodes in the study of normal 3 cpm GMA in humans. These studies have led to understanding gastric dysthymias are present in various nausea syndromes. In addition, a functional obstructive gastroparesis subtype was described that reflects pyloric dysfunction and response to endoscopic therapies with botulinum toxin A injection or balloon dilation. Dr. Koch is a PI in the NIH-sponsored Gastroparesis Clinical Research Consortium. Dr. Koch has written 143 peer-reviewed publications, 43 chapters, and 2 books.
 
This program is sponsored by the Association of Gastrointestinal Motility Disorders, Inc. | AGMD |